Emerald Health Launches Sublingual Tablets

Emerald Health Therapeutics Inc. (TSX-V: EMH, OTCQX: EMHTF,Forum) launched its new product line, SYNC Tabs on Tuesday, an innovative, naturally-flavoured ingestible offering consumers a controlled 10 mg THC dose.

EMH President and Chief Executive Of…

For further details see:


Emerald Health Launches Sublingual Tablets